About NVision Imaging Technologies

NVision has developed a platform which polarizes natural metabolites, enabling these safe molecules to be used as an agent for imaging tumor metabolism via MRI. The company's technology uses quantum physics advances to disrupt the medical imaging and diagnostics space by allowing standard Magnetic Resonance Spectrometers to assess human metabolism, allowing healthcare professionals to perform advanced cancer diagnosis and real-time monitoring of response to therapy.

Top 100 in Health Diagnostics
Top 100 in Pharmaceutical
Top 100 in Biopharma
Top 100 in Health Care in Germany
Top 100 in Health Diagnostics in Germany
Top 100 in Medical in Germany
Top 100 in Pharmaceutical in Germany
Top 100 in Biotechnology in Germany
Top 100 in Medical Device in Germany
Top 100 in Biopharma in Germany
Company Highlights
Year Founded

2015

icon-altEmployees

67

Location (HQ)

DEU

Since Last Funding

1 year 2 months

Monthly Website Visitors

1.9K

icon-altTotal Investment Amt

$52M

Last Funding Round

Series A

icon-altMoM Headcount Growth

3.07%

icon-altYoY Headcount Growth

48.78%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Nanotechnology Research

Health Diagnostics

Biopharma

Nanotechnology